Roche's Genentech Gets FDA Priority Approval For Polivy Regimen

Date : 06/10/2019 @ 4:58PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 38.395  0.0 (0.00%) @ 12:16PM

Roche's Genentech Gets FDA Priority Approval For Polivy Regimen

Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart

6 Months : From Jun 2019 to Dec 2019

Click Here for more Roche Holding (QX) Charts.

By Colin Kellaher


The U.S. Food and Drug Administration on Monday said it granted accelerated approval to Roche Holdings AG's (ROG.EB) Genentech unit for Polivy as part of the first chemoimmunotherapy regimen for patients with the most common type of non-Hodgkin lymphoma.

The agency said the approval covers Polivy in combination with the chemotherapy bendamustine and a rituximab product in adults with diffuse large B-cell lymphoma that has progressed or returned after at least two prior therapies.

Roche markets the cancer drug rituximab under the name Rituxan. The FDA earlier this year granted priority review to the Polivy combination, with a target action date of Aug. 19.

The FDA's accelerated approval process enables the agency to approve drugs for serious conditions to fill an unmet medical need based on an endpoint that is reasonably likely to predict a clinical benefit to patients. The FDA said further clinical trials are required to verify and describe Polivy's clinical benefit.


Write to Colin Kellaher at


(END) Dow Jones Newswires

June 10, 2019 12:43 ET (16:43 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.